MTOR and central nervous system cancer: Similarly NVP-BEZ235—another a novel PI3K/mTOR inhibitor—had exhibited promising autophagy induction and enhanced radiosensitivity and apoptosis in human glioma stem cells (157) through blocking the DNA damage repairing pathway.